BDBM385627 US10287292, Compound 1.022::US11059825, Compound 1.022

SMILES Cc1cn2cccc2c(n1)N1CC[C@@H](C1)NC(=O)c1ncn(n1)-c1ccc(Cl)cc1

InChI Key InChIKey=XETXLFMBBBCJDP-INIZCTEOSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 385627   

TargetAtypical chemokine receptor 3(Homo sapiens (Human))
Chemocentryx

US Patent
LigandPNGBDBM385627(US10287292, Compound 1.022 | US11059825, Compound ...)
Affinity DataIC50: <500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAtypical chemokine receptor 3(Homo sapiens (Human))
Chemocentryx

US Patent
LigandPNGBDBM385627(US10287292, Compound 1.022 | US11059825, Compound ...)
Affinity DataIC50: <500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent